The device has the potential to reduce the length of stay for ADHF patients by measuring their response to diuretic medication in real time using algorithms, allowing the process of removing fluid to be more efficient.

At age 30, she was diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetically inherited condition. She is the fourth generation in her family to face it. And the first to survive it.   

With the addition of the J-Valve device, Vanderbilt Health now offers minimally invasive procedures to implant devices treating every valve disease. The trial is still enrolling new patients, so other high-risk patients with aortic regurgitation could qualify.

A Chattanooga patient says she’s feeling great after becoming the first to receive the robotic‑assisted central line in Nashville.

Her care illustrates the multidisciplinary expertise of the Vanderbilt Women’s Heart Center, Cardiac OB/High-Risk Pregnancy Team and maternal-fetal medicine specialists.

Heather Burich had just driven to Clarksville after an appointment on Vanderbilt Health's Nashville campus when she got a call from a doctor she was yet to meet. The news about her echocardiogram results was alarming.

Hospitals that earn ACC Chest Pain Center Accreditation have proven exceptional competency in treating patients with heart attack symptoms.